About Ricaptos
Ricaptos is a company based in Paonta Sahib (India) founded in 2019 by Gururaj R. It operates as a B2B. Ricaptos offers products and services including Injectables, Oral Drugs, and Eye and Ear Drops. Ricaptos operates in a competitive market with competitors including Sana Biotechnology, Janux Therapeutics, GigaGen, Tenaya Therapeutics and Cellino, among others.
- Headquarter Paonta Sahib, India
- Founders Gururaj R
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ricaptos Biocare Private Limited
- Date of Incorporation 26 Apr, 2019
- Jurisdiction Paonta Sahib, Himachal Pradesh, India
-
Annual Revenue
$292.9 K (USD)426.11as on Mar 31, 2022
-
Net Profit
$7.65 K (USD)187.92as on Mar 31, 2022
-
EBITDA
$10.37 K (USD)312.49as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ricaptos
Ricaptos offers a comprehensive portfolio of products and services, including Injectables, Oral Drugs, and Eye and Ear Drops.
Sterile drugs for medical treatments and injections
Tablets and capsules for oral health administration
Solutions for eye and ear care treatments
Funding Insights of Ricaptos
Detailed funding history for Ricaptos
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ricaptos
Investment portfolio details for Ricaptos
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ricaptos
Detailed financials for Ricaptos
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ricaptos Comparisons
Peer comparison for Ricaptos
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ricaptos
Ricaptos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sana Biotechnology, Janux Therapeutics, GigaGen, Tenaya Therapeutics and Cellino, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
Immunotherapeutics for cancer treatment are developed to target solid tumors.
|
|
| Locked | Locked | Locked |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms.
|
|
| Locked | Locked | Locked |
Regenerative and gene therapeutics for heart failure are developed.
|
|
| Locked | Locked | Locked |
Developer of autologous cell therapies
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for cancer treatment are developed.
|
Detailed competitors of Ricaptos
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ricaptos
Complete news archive for Ricaptos
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ricaptos
Ricaptos was founded in 2019.
Ricaptos is headquartered in Paonta Sahib, India. It is registered at Paonta Sahib, Himachal Pradesh, India.
Gururaj R is the current CEO of Ricaptos. They have also founded this company.
Annual revenue of Ricaptos is $292.9K as on Mar 31, 2022.
Ricaptos Biocare is a third-party manufacturing company based in India, specializing in pharmaceutical preparations such as oral drugs, injectables, and eye drops. It operates from offices in Bangalore and Paonta Sahib, focusing on innovation, quality assurance, and exports. The company partners with pharmaceutical giants for in-licensing, out-licensing, and production, aiming to improve patient care through reliable solutions.
Ricaptos's top competitors include Janux Therapeutics, Kronos Bio and Sana Biotechnology.
Ricaptos offers Injectables, Oral Drugs, and Eye and Ear Drops.